tiprankstipranks
Biovaxys Technology Corp (BVAXF)
:BVAXF
US Market

BioVaxys Technology (BVAXF) Income Statement

Compare
31 Followers

BioVaxys Technology Income Statement

Last quarter (Q3 2024), BioVaxys Technology's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, BioVaxys Technology's net income was C$-1.19M. See BioVaxys Technology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 2.40MC$ 4.08MC$ 6.44MC$ 1.10MC$ 229.91K
Depreciation and Amortization
C$ 2.40MC$ 3.80MC$ 5.98MC$ 1.01MC$ 183.34K
EBITDA
C$ -7.69MC$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Income
C$ -2.40MC$ -4.08MC$ -6.42MC$ -1.09MC$ -229.69K
Other Income/Expenses
C$ -5.28MC$ -7.65MC$ -478.68KC$ -93.55KC$ -33.54K
Pretax Income
C$ -7.69MC$ -11.73MC$ -6.46MC$ -1.10MC$ -230.12K
Net Income
C$ -7.69MC$ -19.36MC$ -6.47MC$ -1.18MC$ -230.33K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.06C$ -0.20C$ -0.08C$ -0.02C$ -0.01
Diluted EPS
C$ -0.06C$ -0.20C$ -0.08C$ -0.02C$ -0.01
Weighted Average Shares Outstanding
134.15M 98.18M 82.93M 56.42M 20.77M
Weighted Average Shares Outstanding (Diluted)
134.14M 98.18M 82.93M 56.42M 20.77M
Currency in CAD

BioVaxys Technology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis